Efficacy and safety of doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF) in treatment-naive adults with HIV-1 and transmitted nonnucleoside reverse transcriptase inhibitor resistance mutations

TitleEfficacy and safety of doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF) in treatment-naive adults with HIV-1 and transmitted nonnucleoside reverse transcriptase inhibitor resistance mutations
Publication TypeJournal Article
Year of Publication2019
AuthorsWong, A., D. Goldstein, J. Mallolas, E. DeJesus, M. Johnson, J-M. Molina, A. Pozniak, A. Rodgers, V. Teal, D. Hepler, and others
JournalJournal of acquired immune deficiency syndromes (1999)
Volume82
Paginatione47